Table 2. Change in the prevalence of nonadherence to statins after retirement in the patient subgroups not discontinuing their therapy.
Nonadherence a after vs. before retirementPrevalence ratio b (95% Confidence interval) | ||
---|---|---|
Characteristic | Men | Women |
All | 1.23 (1.17–1.29) | 1.19 (1.13–1.26) |
Retirement age (years) | ||
44–63 | 1.22 (1.14–1.31) | 1.23 (1.14–1.32) |
64–68 | 1.24 (1.16–1.32) | 1.16 (1.08–1.25) |
Educational level | ||
Compulsory school | 1.20 (1.11–1.31) | 1.14 (1.01–1.29) |
Upper secondary school | 1.21 (1.13–1.30) | 1.22 (1.12–1.31) |
University education | 1.30 (1.18–1.42) | 1.19 (1.00–1.30) |
Married | ||
Yes | 1.23 (1.13–1.34) | 1.12 (1.03–1.22) |
No | 1.23 (1.17–1.31) | 1.25 (1.17–1.33) |
Income (SEK/year) | ||
<250 000 | 1.20 (1.11–1.30) | 1.23 (1.15–1.31) |
≥250 000 | 1.25 (1.17–1.32) | 1.15 (1.06–1.25) |
Type of retirement | ||
Statutory | 1.24 (1.17–1.31) | 1.16 (1.08–1.24) |
Disability | 1.20 (1.10–1.31) | 1.26 (1.16–1.37) |
Type of prevention | ||
Primary | 1.18 (1.13–1.25) | 1.18 (1.11–1.24) |
Secondary c | 1.38 (1.26–1.54) | 1.43 (1.18–1.72) |
Prevalence ratios were derived from repeated measures log-binomial regression analyses adjusted for age at retirement.
aNonadherence refers to proportion of days covered by treatment <80%.
bPrevalence ratio for nonadherence in the 2 years after retirement compared with the 2 years before retirement.
c Secondary prevention: previous in- or outpatient hospital visits due to coronary heart disease or cerebrovascular diseases in any year before retirement.